Canada became the first country in the world that has authorized the use of a plant-based COVID-19 vaccine. The two-dose vaccine of Medicago Inc. (a biopharma company owned by Mitsubishi Chemical and Philip Morris), can be given to adults who are aged between 18 to 64, but little data is available on the shots received by people aged 65 and above.
Buy Prime Test Series for all Banking, SSC, Insurance & other exams
The decision to authorize the vaccine was based on a study conducted on 24,000 adults that showed the efficacy rate of the vaccine is 71% at preventing COVID-19 – although the tests were conducted before the omicron variant emerged. Covifenz is the name given to this vaccine. Canada agreed to buy 20 million doses of this plant-based vaccine, with an option to purchase 56 million additional doses.
Important takeaways for all competitive exams:
Imagine when you check clock at the midnight and outside window you find out sun…
Can you imagine, if a single mango tree could produce the hundreds of different varieties…
Have you ever wondered how the some places on earth earn their respective names which…
The Central Government of India has approved the appointment of the five new judges to…
On June 2nd, 2026 celebrates the Telangana Formation Day every year since the formation of…
As Myanmar President Min Aung Hlaing his official visit of India from 30 May to…